AstraZeneca (AZN) Tops Q2 EPS by 4c

AstraZeneca (NYSE: AZN) reported Q2 EPS of $1.20, $0.04 better than the analyst estimate of $1.16. Revenue for the quarter came in at $6.23 billion versus the consensus estimate of $6.24 billion.

The Board has recommended a first interim dividend of $0.90.

For earnings history and earnings-related data on AstraZeneca (AZN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy